News articles about Stericycle (NASDAQ:SRCL) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Stericycle earned a daily sentiment score of 0.16 on Accern’s scale. Accern also gave news headlines about the business services provider an impact score of 46.697609499 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Stericycle (SRCL) traded up $0.02 during midday trading on Friday, reaching $71.60. 857,500 shares of the company’s stock were exchanged, compared to its average volume of 653,111. The firm has a market capitalization of $6,120.00, a price-to-earnings ratio of -127.86, a PEG ratio of 1.73 and a beta of 0.16. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle has a one year low of $61.25 and a one year high of $88.00.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.04). The firm had revenue of $883.00 million during the quarter, compared to analysts’ expectations of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The firm’s revenue was down .8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.24 EPS. research analysts anticipate that Stericycle will post 4.49 EPS for the current year.

Several brokerages recently commented on SRCL. Zacks Investment Research upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research note on Wednesday. BidaskClub lowered shares of Stericycle from a “hold” rating to a “sell” rating in a research note on Thursday. William Blair restated an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. Royal Bank of Canada dropped their price objective on shares of Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a research note on Thursday, November 9th. Finally, Oppenheimer restated a “hold” rating on shares of Stericycle in a research note on Wednesday, December 13th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $74.45.

In other news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $70.52, for a total value of $1,392,981.56. Following the sale, the director now owns 205,576 shares of the company’s stock, valued at $14,497,219.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In the last ninety days, insiders sold 79,012 shares of company stock worth $5,240,668. Insiders own 3.50% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Insider Buying and Selling by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.